- -------------------------------------------------------------------
- -------------------------------------------------------------------
FORM 10-Q
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Quarterly Report Under Section 13 or 15 (d)
of the Securities Exchange Act of 1934
For Quarter Ended March 31, 2000
Commission File Number 1-8351
CHEMED CORPORATION
(Exact name of registrant as specified in its charter)
Delaware 31-0791746
(State or other jurisdiction of (IRS Employer Identification No.)
incorporation or organization)
2600 Chemed Center, 255 E. Fifth Street, Cincinnati, Ohio 45202
(Address of principal executive offices) (Zip code)
(513) 762-6900
(Registrant's telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all
reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file
such reports) and (2) has been subject to such filing requirements
for the past 90 days. Yes X No
---- ----
Indicate the number of shares outstanding of each of the issuer's
classes of common stock, as of the latest practicable date.
Class Amount Date
Capital Stock 9,939,358 Shares April 30, 2000
$1 Par Value
- ------------------------------------------------------------------
- ------------------------------------------------------------------
Page 1 of 12
CHEMED CORPORATION AND
SUBSIDIARY COMPANIES
Index
Page No.
PART I. FINANCIAL INFORMATION:
Item 1. Financial Statements
Consolidated Balance Sheet -
March 31, 2000 and
December 31, 1999 3
Consolidated Statement of Income -
Three months ended
March 31, 2000 and 1999 4
Consolidated Statement of Cash Flows -
Three months ended
March 31, 2000 and 1999 5
Notes to Unaudited Financial Statements 6 - 8
Item 2. Management's Discussion and Analysis of
Financial Condition and Results of
Operations 9 - 11
PART II. OTHER INFORMATION 12
Page 2 of 12
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
CHEMED CORPORATION AND SUBSIDIARY COMPANIES
CONSOLIDATED BALANCE SHEET
(in thousands except share and per share data)
UNAUDITED
March 31, December 31,
2000 1999
---------- ----------
ASSETS
Current assets
Cash and cash equivalents $ 13,825 $ 17,282
Accounts receivable, less allowances of $4,824
(1999 - $4,554) 53,239 55,889
Inventories 10,008 9,794
Statutory deposits 14,363 14,254
Other current assets 15,945 14,583
---------- ----------
Total current assets 107,380 111,802
Other investments 37,138 37,849
Properties and equipment, at cost less accumulated
depreciation of $58,618 (1999 - $55,410) 72,275 71,728
Identifiable intangible assets less accumulated
amortization of $6,853 (1999 - $6,558) 12,471 12,597
Goodwill less accumulated amortization of $27,780
(1999 - $26,545) 172,217 163,257
Other assets 25,755 24,070
---------- ----------
Total Assets $ 427,236 $ 421,303
========== ==========
LIABILITIES
Current liabilities
Accounts payable $ 10,228 $ 11,246
Current portion of long-term debt 11,412 11,719
Income taxes 11,442 8,714
Deferred contract revenue 26,460 25,630
Other current liabilities 36,400 41,119
---------- ----------
Total current liabilities 95,942 98,428
Long-term debt 83,527 78,580
Other liabilities 32,730 32,251
---------- ----------
Total Liabilities 212,199 209,259
---------- ----------
MANDATORILY REDEEMABLE CONVERTIBLE PREFERRED SECURITIES
OF THE CHEMED CAPITAL TRUST 15,539 -
---------- ----------
STOCKHOLDERS' EQUITY
Capital stock-authorized 15,000,000 shares $1 par;
issued 13,885,837 shares (1999 - 13,664,892 shares) 13,886 13,665
Paid-in capital 170,523 164,549
Retained earnings 148,205 144,322
Treasury stock - 3,944,343 shares
(1999 - 3,268,783 shares), at cost (117,882) (99,437)
Unearned compensation (20,788) (17,056)
Deferred compensation payable in company stock 5,446 5,340
Accumulated other comprehensive income 2,879 3,392
Notes receivable for shares sold (2,771) (2,731)
---------- ----------
Total Stockholders' Equity 199,498 212,044
---------- ----------
Total Liabilities and Stockholders' Equity $ 427,236 $ 421,303
========== ==========
See accompanying notes to unaudited financial statements.
Page 3 of 12
CHEMED CORPORATION AND SUBSIDIARY COMPANIES
CONSOLIDATED STATEMENT OF INCOME
UNAUDITED
(in thousands except per share data)
Three Months Ended
March 31,
-----------------------
2000 1999*
--------- ---------
Service revenues and sales $121,534 $105,735
--------- ---------
Cost of services provided and cost of goods sold 74,127 65,059
Selling and marketing expenses 11,264 9,979
General and administrative expenses 24,846 21,875
Depreciation 3,758 3,030
--------- ---------
Total costs and expenses 113,995 99,943
--------- ---------
Income from operations 7,539 5,792
Interest expense (1,782) (1,594)
Distributions on preferred securities (288) -
Other income - net 2,396 4,609
--------- ---------
Income before income taxes 7,865 8,807
Income taxes (2,963) (3,452)
--------- ---------
Net Income $ 4,902 $ 5,355
========= =========
Earnings Per Common Share
Net income $ .49 $ .51
========= =========
Average number of shares outstanding 10,064 10,471
========= =========
Diluted Earnings Per Common Share
Net income $ .48 $ .51
========= =========
Average number of shares outstanding 10,171 10,516
========= =========
Cash Dividends Paid Per Share $ .10 $ .53
========= =========
* Reclassified to conform to 2000 presentation.
See accompanying notes to unaudited financial statements.
Page 4 of 12
CHEMED CORPORATION AND SUBSIDIARY COMPANIES
CONSOLIDATED STATEMENT OF CASH FLOWS
UNAUDITED
(in thousands)
Three Months Ended
March 31,
-----------------------
2000 1999*
--------- ----------
Cash Flows From Operating Activities
Net income $ 4,902 $ 5,355
Adjustments to reconcile net income to net cash
provided by operating activities:
Depreciation and amortization 5,811 4,794
Gains on sale of investments (951) (3,068)
Provision for uncollectible accounts receivable 112 93
Provision for deferred income taxes (92) (24)
Changes in operating assets and liabilities,
excluding amounts acquired in business
combinations
(Increase)/Decrease in accounts receivable 2,488 (5,119)
Increase in inventories and other current
assets (109) (1,020)
Increase in statutory deposits (1,814) (123)
Increase/(decrease) in accounts payable,
deferred contract revenue and other
current liabilities (3,129) 869
Increase in income taxes 2,725 3,333
Other - net (175) (603)
--------- ---------
Net cash provided by operating activities 9,768 4,487
--------- ---------
Cash Flows From Investing Activities
Business combinations--net of cash acquired (10,827) (5,965)
Capital expenditures (4,283) (5,726)
Proceeds from sale of investments 1,121 5,793
Net proceeds from discontinued operations (599) (686)
Purchase of investments (200) (297)
Other - net 109 1,405
--------- ---------
Net cash used by investing activities (14,679) (5,476)
--------- ---------
Cash Flows From Financing Activities
Proceeds from issuances of long-term debt 5,000 -
Purchase of treasury stock (2,508) (26)
Dividends paid (1,024) (5,616)
Retirement of long-term debt (79) (1,259)
Other - net 65 112
--------- ---------
Net cash provided/(used) by financing activities (1,454) (6,789)
--------- ---------
Decrease In Cash And Cash Equivalents (3,457) (7,778)
Cash and cash equivalents at beginning of period 17,282 41,358
--------- ---------
Cash and cash equivalents at end of period $ 13,825 $33,580
========= =========
*Reclassified to conform to current year presentation.
See accompanying notes to unaudited financial statements.
Page 5 of 12
CHEMED CORPORATION AND SUBSIDIARY COMPANIES
Notes to Unaudited Financial Statements
1. The accompanying unaudited consolidated financial statements
have been prepared in accordance with Rule 10-01 of SEC
Regulation S-X. Consequently, they do not include all the
disclosures required under generally accepted accounting
principles for complete financial statements. However, in
the opinion of the management of Chemed Corporation (the
"Company"), the financial statements presented herein contain
all adjustments, consisting only of normal recurring
adjustments, necessary to present fairly the financial
position, results of operations and cash flows of the Company
and its consolidated subsidiaries ("Chemed"). For further
information regarding Chemed's accounting policies, refer to
the consolidated financial statements and notes included in
Chemed's Annual Report on Form 10-K for the year ended
December 31, 1999.
2. The Company's previously announced Exchange Offer, whereby
stockholders were permitted to exchange up to 2,000,000
shares of capital stock for Mandatorily Redeemable
Convertible Preferred Securities ("Trust Securities") of the
wholly-owned Chemed Capital Trust ("Trust") on a one-for-one
basis, was completed effective February 1, 2000. As a result
575,503 shares of capital stock were exchanged for the same
number of Trust Securities with a redemption value of
$15,538,581 ($27 per security).
The Trust Securities pay an annual cash distribution of $2.00
per security (payable at the quarterly rate of $.50 per
security commencing March 2000) and are convertible into
capital stock at a price of $37 per security. The Trust
Securities mature in 30 years and are callable three years
after issuance.
The sole assets of the Trust are Junior Subordinated
Debentures ("Debentures") of the Company in the principal
amount of $16,019,181. The Debentures mature in March 2030
and the interest rate on the Debentures is $2.00 per annum
per $27 principal amount. In February 2000, the Company
executed an Indenture relating to the Debentures, an Amended
and Restated Declaration of Trust relating to the Trust
Securities and a Guarantee Agreement for the benefit of the
holders of the Trust Securities (collectively "Back-up
Undertakings"). Considered together, the Back-up
Undertakings constitute a full and unconditional guarantee by
the Company of the Trust's obligations under the Trust
Securities.
Page 6 of 12
3. Sales and service revenues and aftertax earnings by business
segment follow (in thousands):
Three Months Ended
March 31,
-------------------
2000 1999
------- --------
Sales and Service
Revenues
-----------------
Roto-Rooter $ 67,724 $ 56,206
Patient Care 32,909 30,212
Service America 18,754 17,661
Cadre Computer 2,147 1,656
-------- -------
Total $121,534 $105,735
======== ========
Aftertax Earnings
----------------
Roto-Rooter $ 4,669 $ 3,197
Patient Care 403(a) 652
Service America 320 539
Cadre Computer 42 4
-------- --------
Total segment earnings 5,434 4,392
Corporate
Gains on sales of
investments 677 1,934
Overhead (1,363) (1,302)
Net investing and financing
income/(expense) 154 331
-------- --------
Net income $ 4,902 $ 5,355
======== ========
------------------
(a) Includes aftertax income from favorable adjustments to
prior years' cost reports ($130,000) and net adjustments
to the allowance for doubtful accounts ($94,000).
4. Earnings per common share are computed using the weighted
average number of shares of capital stock outstanding.
Diluted earnings per common share are computed as follows on
the next page (in thousands except per share data):
Page 7 of 12
Three Months Ended
March 31,
-------------------
2000 1999
------- -------
Reported income $ 4,902 $ 5,355
Aftertax interest on Trust
Securities (a) - -
------- -------
Adjusted income $ 4,902 $ 5,355
======= =======
Average number of shares
outstanding 10,064 10,471
Effect of conversion of the
Trust Securities (a) - -
Effect of nonvested stock
awards 106 43
Effect of unexercised stock
options 1 2
------- -------
Average number of shares used
to compute diluted earnings
per common share 10,171 10,516
======= =======
Diluted earnings per common
share $ .48 $ .51
======= =======
------------------
(a) The impact of potential conversion of the Trust
Securities is currently anti-dilutive.
5. During the first quarter of 2000, the Company acquired two
businesses in the Roto-Rooter segment for aggregate purchase
prices of $10.5 million in cash. These operations provide
plumbing repair and sewer and drain cleaning services
primarily to residential customers.
Approximately $10.2 million of the purchase price was
allocated to goodwill and is being amortized over forty
years. The results of operations of the acquired businesses
were not material in relation to the Company's results in
2000.
6. The Company had total comprehensive income/(loss) of
$4,389,000 and $(2,136,000) for the three months ended
March 31, 2000 and 1999, respectively. The difference
between the Company's net income and comprehensive income
relates to the cumulative unrealized
appreciation/depreciation on its available-for-sale
securities.
Page 8 of 12
Item 2. Management's Discussion and Analysis
of Financial Condition and Results of Operations
Financial Condition
- -------------------
The decline in other current liabilities from $41.1
million at December 31, 1999 to $36.4 million at March 31, 2000
is due largely to the payment of liabilities for 1999
supplemental thrift and profit sharing contributions and
incentive compensation. Also, the decline in stockholders'
equity from $212 million at December 31, 1999 to $199.5 million
at March 31, 2000 is attributable primarily to the completion of
the Company's Exchange Offer in February 2000. Under the
Exchange Offer, approximately 576,000 shares of capital stock
were exchanged for the same number of Mandatorily Redeemable
Convertible Preferred Securities of the Chemed Capital Trust.
The exchanged shares of capital stock were recorded in treasury
stock. The Trust Securities are callable in three years and are
redeemable in 2030.
Vitas Healthcare Corporation ("Vitas"), the privately-
held provider of hospice services to the terminally ill in which
the Company carries an investment of $27 million of redeemable
preferred stock, is continuing to explore long-term financing
alternatives to increase its liquidity. As of March 31, 2000,
preferred dividends of $715,000 remain in arrears. The Company
is currently negotiating with Vitas concerning terms for
repayment of the preferred stock and/or extension of the
redemption date (currently April 1, 2000). Vitas' operating
results and net income continue to meet its management's
expectations. On the basis of current information, management
believes the Company's investment in Vitas is fully recoverable
and that no impairment exists.
At March 31, 2000 Chemed had approximately $96.6
million of unused lines of credit with various banks. Management
believes its liquidity and sources of capital are satisfactory
for the Company's needs in the foreseeable future.
Page 9 of 12
Results of Operations
- ---------------------
Data relating to (a) the increase or decrease in
service revenues and sales and (b) aftertax earnings as a percent
of service revenues and sales for each segment are set forth
below:
Service Revenues Aftertax Earnings
and Sales - as a % of Revenues
% Increase (Aftertax Margin)
---------------- - -----------------
2000 vs. 1999 2000 1999
---------------- ------------------
Roto-Rooter 20 % 6.9% 5.7%
Patient Care 9 1.2 2.2
Service America 6 1.7 3.1
Total 15 4.5 4.2
Service revenues and sales for the Roto-Rooter segment
for the first quarter of 2000 totalled $67,724,000, an increase
of 20% over the $56,206,000 recorded in the first quarter of
1999. Revenues of the plumbing services business and the drain
cleaning business increased 17% and 23%, respectively, for the
first quarter of 2000, as compared with revenues recorded in the
first quarter of 1999. These revenues accounted for 40% and 43%,
respectively, of Roto-Rooter's total service revenues and sales
during the 2000 period. Excluding businesses acquired in 1999
and 2000, revenues of this segment increased 15% during the first
quarter of 2000. The aftertax margin of the Roto-Rooter segment
in the first quarter of 2000 was 6.9% as compared with 5.7%
during the first quarter of 1999. This increase was attributable
to a higher gross profit margin in 2000 and to operating
leverage, as selling and marketing and general and administrative
expenses increased at lesser rates than did service revenues and
sales.
Service revenues of the Patient Care segment increased
9% from $30,212,000 during the first quarter of 1999 to
$32,909,000 in the first quarter of 2000. Excluding the revenues
of businesses acquired in 1999, this revenue increase was 4%.
During the first quarter of 2000, the aftertax margin of this
segment declined from 2.2% during the first quarter of 1999 to
1.2% during the 2000 quarter, primarily as the result of higher
general and administrative costs (as a percentage of service
revenues) and higher interest costs. The increase in interest
costs was attributable to the use of capital for acquisitions in
1999, increased working capital levels and higher interest rates
in 2000. Favorable adjustments to prior years' cost reports and
bad debt allowances in the 2000 quarter partially offset the
impact of higher general and administrative and interest
expenses.
Page 10 of 12
Service revenues and sales of the Service America
segment increased 6% from $17,661,000 in the first quarter of
1999 to $18,754,000 in the first quarter of 2000. This revenue
increase was highlighted by a 32% increase in the revenues of
Service America's retail business, which accounted for
approximately 25% of its overall sales in the 2000 period. The
aftertax margin of this segment declined from 3.1% during the
first quarter of 1999 to 1.7% during the first quarter of 2000.
This decline was attributable primarily to a decline in the gross
profit margin in 2000, largely as a result of higher overtime
costs and higher material costs incurred in 2000.
Income from operations increased from $5,792,000 in the
first three months of 1999 to $7,539,000 during the first three
months of 2000. This increase was attributable primarily to
higher operating profit of the Roto-Rooter segment.
Other income--net declined from $4,609,000 in the first
quarter of 1999 to $2,396,000 in the first quarter of 2000,
primarily as a result of lower investment gains recorded in the
2000 period. During the first quarter of 2000 the Company
recorded gains on the sales of investments aggregating $951,000
as compared with $3,068,000 during the first quarter of 1999.
Lower interest income for 2000 as compared with the 1999 first
quarter also contributed to the decline in other income.
The Company's effective income tax rate during the
first quarter of 2000 was 37.7% as compared with 39.2% during the
first three months of 1999. This decline is due primarily to
lower effective state and local income tax rates in the 2000
first quarter.
Net income during the first quarter of 2000 totalled
$4,902,000 ($.49 per share) as compared with $5,355,000 ($.51 per
share) in the first quarter of 1999. This decline was
attributable primarily to larger gains on the sales of
investments in the 1999 period. Excluding gains on the sales of
investments in both periods, net income for the first quarter of
2000 totalled $.42 per share as compared with $.33 per share
during the first quarter of 1999.
Page 11 of 12
PART II -- OTHER INFORMATION
----------------------------
Item 6. Exhibits and Reports on Form 8-K
(a) Exhibits
--------
Exhibit SK 601 Page
No. Ref. No. Description No.
------- -------- ------------------ -------
1 (27) Financial Data
Schedule E-1
SIGNATURES
Pursuant to the requirements of the Securities Exchange
Act of 1934, the Registrant has duly caused this report to
be signed on its behalf by the undersigned thereunto duly
authorized.
Chemed Corporation
-------------------------
(Registrant)
Dated: May 10, 2000 By Naomi C. Dallob
---------------------- -------------------------
Naomi C. Dallob, Vice
President and Secretary
Dated: May 10, 2000 By Arthur V. Tucker, Jr.
---------------------- -------------------------
Arthur V. Tucker, Jr.
Vice President and
Controller (Principal
Accounting Officer)
Page 12 of 12
5
0000019584
CHEMED CORPORATION
1,000
U.S. DOLLARS
3-MOS
DEC-31-2000
JAN-01-2000
MAR-31-2000
1.0
13825
0
58063
(4824)
10008
107380
130893
(58618)
427236
95942
83527
15539
0
13886
185612
427236
0
121534
0
74127
0
112
1782
7865
2963
4902
0
0
0
4902
0.49
0.48
5
0000019584
CHEMED CORPORATION
1,000
U.S. DOLLAR
3-MOS 6-MOS 9-MOS
DEC-31-1999 DEC-31-1999 DEC-31-1999
JAN-01-1999 JAN-01-1999 JAN-01-1999
MAR-31-1999 JUN-30-1999 SEP-30-1999
1.0 1.0 1.0
33580 22574 20197
0 0 0
54058 52875 56128
(3422) (3425) (3691)
9910 9652 9267
123455 110039 109664
110175 118964 123671
(46925) (49251) (52226)
422347 417887 420093
90630 88013 86566
81063 79770 84764
0 0 0
0 0 0
13662 13659 13665
202745 201762 201117
422347 417887 420093
0 0 0
105735 217120 331548
0 0 0
65059 133432 203470
0 0 0
93 165 231
1594 3101 4549
8807 17234 24758
3452 6765 9877
5355 10469 14881
0 0 0
0 0 0
0 0 0
5355 10469 14881
.51 1.00 1.42
.51 1.00 1.41